General Information of the Compound
| Compound ID |
CP0371881
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
5,7-dibromo-9H-pyrido[3,4-b]indol-6-ol
Show/Hide
|
||||||||||||||||||
| Synonyms |
101927-49-5
5,7-Dibromo-9H-prido(3,4-b)indol-6-ol
5,7-dibromo-9H-pyrido[3,4-b]indol-6-ol
7-Bromoeudistomine D
7-bromo-eudistomin D
9H-Prido(3,4-b)indol-6-ol, 5,7-dibromo-
AC1L2SZQ
BDBM50207817
Bromo-eudistomin D
Bromoeudistomin D
CHEMBL272185
DTXSID80144350
SCHEMBL7085913
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C11H6Br2N2O
|
||||||||||||||||||
| Molecular Weight |
341.99
|
||||||||||||||||||
| Canonical SMILES |
Oc1c(Br)cc2[nH]c3cnccc3c2c1Br
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C11H6Br2N2O/c12-6-3-7-9(10(13)11(6)16)5-1-2-14-4-8(5)15-7/h1-4,15-16H
Show/Hide
|
||||||||||||||||||
| InChIKey |
UNIUKKWPGRGSRQ-UHFFFAOYSA-N
|
||||||||||||||||||
| CAS |
101927-49-5
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00840, Adenosine receptor A1
Protein ID: PT00862, Adenosine receptor A2a
Protein ID: PT01279, Adenosine receptor A3
Clinical Information about the Compound